Bengaluru, 20th May, 2022: International Finance Corporation (IFC) India Country Head, Wendy Werner, visited a rural health camp organized by health-tech company Niramai that offers non-invasive and radiation-free breast cancer screenings. Wendy showcased IFC’s support towards innovation and opportunities for the underserved in India by engaging with the women participants at the event.

Held at PHC Kodathi, Sarjapur Main Road, (behind Wipro SEZ), the event received an overwhelming response with 180+ women participating, including anganwadi workers and nurses, among others. The camp had 5 booths where women could get screened in a privacy-aware manner with no one else present. 7 technicians from Niramai were present to educate the women about breast health and facilitate a smooth screening experience. Wendy also interacted with the women who had already undergone the screening to learn about their experience. In India, IFC’s focus is on growth and diversification of its country portfolio while supporting inclusive and sustainable development in the region.

Speaking at the camp, Wendy Werner, Country Head-India, IFC, said, “As the largest multilateral investor in healthcare in developing countries, we recognize the power of innovative healthcare solutions.” She added, “Breast cancer, already the most prevalent cancer among Indian women, has become a major health concern in the country. By supporting Niramai’s digital health solution, IFC reiterates its commitment to help improve women’s health and safety in emerging markets. Moving forward, especially in a post-COVID world, new technologies can potentially alter the health-care ecosystem rapidly, increasing access to affordable and quality healthcare across the country and the region.”

Also Read: Breast Cancer in women- Various myths and its management 

Dr. Geetha Manjunath, CEO & Co-founder, Niramai, said, “Niramai has developed this affordable, accessible and accurate breast cancer screening test to bridge the gap in healthcare infrastructure in our country. We are thankful to IFC and World Bank for recognizing our contributions to this field and conferring the Global Women Healthtech Award to Niramai earlier this year. Now, I am so glad that Ms Wendy took her valuable time off to visit the camp site, speak with the beneficiaries and endorse her strong commitment to women’s health. It is a matter of pride for us at Niramai to receive the support of IFC for sponsoring such a large health camp.”

Niramai has so far conducted over 4000 camps for the underprivileged and screened over 55000 women. NIRAMAI Health Analytix is a deep-tech healthcare company offering a novel AI-based, radiation-free, non-touch, highly accurate, breast cancer screening test for women of all age groups. The solution is portable, automated and detects breast cancer at a much earlier stage than traditional screening methods.

Niramai is available in Apollo Clinics, HCG Hospital, Rainbow hospital and 100+ other reputed diagnostic centers and cancer hospitals in 25 Indian cities. They recently partnered with home healthcare providers like Healthians in Delhi/NCR region, Ikigai Services Pvt. Ltd. in Mumbai and AMTZ in Andhra Pradesh to conduct breast health test at home on a large scale. Anyone interested in taking their home test can book an appointment on the Niramai website, www.niramai.com.

The post IFC India country head Wendy Werner supports rural health camps conducted by Niramai appeared first on Health Vision.

Bengaluru/ Kerala, 26th October, 2020: Dr. Ambadi’s Calicut Centre for Surgery (CCS) located at Metromed Hospital has partnered with NIRAMAI Health Analytix, India’s foremost AI-based breast cancer screening company, to offer contact-less,  privacy-sensitive, breast cancer screening services to customers.

Niramai’s innovative solution called ‘Thermalytix’, is an automated breast health screening and diagnostic tool, which combines thermal imaging with artificial intelligence. The solution is non-contact, radiation-free, accurate, automated, and works on women of all age groups. Given that it is portable and low-cost than other methods, the solution makes cancer screening more accessible and affordable to all.

With this collaboration, women can also avail of home-screening services which will bring this novel non-touch breast cancer screening solution to the door-step of homes reducing the need to go to a hospital during the pandemic. Only female technicians will provide this service following all covid safety precautions and women can avail of this service with a prior appointment. The test will be conducted in complete privacy without any physical contact. NIRAMAI Thermalytix test is appropriate for women of 18 years and above. It is privacy-aware, non-invasive, radiation-free, and can detect the minutest of lumps or other abnormalities.

Dr. Geetha Manjunath, Founder & CEO, Niramai, added, “We are excited to partner with Dr. Ambadi’s Calicut Centre for Surgery to take our clinically proven Thermalytix screening service to many more women in India and help save lives. Today, the pandemic has impacted our lives in an unprecedented way. People are unable to go to hospitals for their regular health check-ups or other ailments. Niramai is providing multiple services to cater to this new requirement. We are also conducting many free programs to raise awareness amongst women about early detection of breast cancer and educating the masses on the importance of frequent checks”.

Dr. Abdurahman Ambadi, Chairman & Chief Laparoscopic Surgeon of CCS, said, “We are committed to offering the best surgical healthcare services to our customers. Collaborating with an innovative company like Niramai to offer early-stage breast screening will surely be beneficial to our patients.”

The post Contactless breast cancer screening appeared first on Health Vision.

The post Breast cancer awareness month: NIRAMAI promoting breast health’ appeared first on Health Vision.

Bengaluru, September24,2020: NIRAMAI, an AI-based health-tech company is organizing its webinar on women’s health around the theme ‘Screening and diagnosis of breast cancer.’ The webinar is comprised of a moderator and a leading radiologist speaking about the techniques used for breast cancer detection.

Experts will answer questions and explain why it’s crucial to keep your appointments for screenings, tests, and treatments during this time and in the future. You’ll have the opportunity to submit your questions when you register or during the webinar.

Panelists:

Expert: Dr. Sudhakar S, Breast Imaging Specialist, HCG Bangalore

He is an integral part of the Radiology Department at the HCG hospital, Bangalore, and is one of the most respected breast imaging and Intervention Radiologists in South-India.

Moderator – Dr. Geetha Manjunath, CEO & CTO, NIRAMAI

Dr. Geetha is a leading data scientist and a healthcare industry veteran with 25+ years of experience to her credit. She is the CEO and CTO of NIRAMAI drives the direction of NIRAMAI for the early detection of breast cancer.

Event Date & Time: 25th September, at 4:00 p.m.

Registration link: http://bit.ly/niramaiwebinar3

The post NIRAMAI announces talk on ‘breast cancer’ appeared first on Health Vision.

The acceptance of clinical results at an eminent peer-reviewed forum like SABCS is a strong validation of Niramai’s trial results. An opportunity to present the work to the international experts and receiving their positive feedback puts Niramai’s indigenous technology on the map together with leading innovations across the globe.

Dr Geetha Manjunath, CEO & CTO, Niramai, spoke about how their innovative solution uses artificial intelligence (AI) for detecting early stage breast cancer with results comparable to standard modalities. Niramai’s solution is called Thermalytix, an automated diagnostic tool, which combines thermal imaging with artificial intelligence. The solution is radiation-free, accurate, automated and works on all women irrespective of their breast density. “We were privileged to get an opportunity to present at SABCS 2018, a prestigious forum for interaction and learning for a broad spectrum of medical practitioners, researchers and health professionals with a special interest in breast cancer,” says Dr Geetha Manjunath.

In the conference, Niramai presented results of a retrospective multisite comparative study of 247 patients across 3 reputed cancer hospitals in India. The results demonstrated higher sensitivity and comparable specificity of the solution to Mammography. The highlight was the good accuracy of the Niramai results among women with dense breasts where Mammography was not effective. The high sensitivity and high Negative Predictive Value of Niramai demonstrated its potential to be the first screening test for detection of breast cancer for women across all age groups. The radiation-free nature of Niramai test will be an added advantage for early screening as it can be used for regular preventive screening without any side effects.

US-based radiologists were very receptive towards Niramai innovative solution and the clinical results presented at SABCS. Dr. Sheldon Feldman, a New York based expert in Breast Surgery & Surgical Oncology, mentioned, “I am very intrigued by this promising technology. It looks like a major advance in technology. I hope to collaborate and be helpful to further validate its efficacy”.  

Dr. Ralph Wolfstein, radiation oncologist based out of Los Angeles, expressed his belief in the benefits of the solution as well. “I think my patients would certainly appreciate this diagnostic test more than they would mammogram as it is non-contact”.

This year, SABCS attracted more than 7,000 participants from more than 80 countries, including medical oncologists, radiation oncologists, researchers, and other healthcare professionals.

About Niramai

NIRAMAI stands for “Non-Invasive Risk Assessment with Machine Intelligence”. In Sanskrit, it means being free from illness. Niramai is a deep-tech startup proposing a radiation free, non-intrusive breast cancer screening solution without being touched. The solution is manageable, precise and confidential, it can also be used for ladies of all ages.

Thermalytix is their main technology that utilize a high resolution thermal sensing instrument and a cloud compered analytics solution for examining thermal pictures. Their SaaS solution utilizes vast data analytics, artificial intelligence and engine learning for dependable, timely and precise breast cancer screening. The pioneering procedures used in Niramai’s solution have led to several US patents and their novel procedures have also been peer-reviewed in global scientific conferences. Niramai’s expertise identifies breast cancer at a much initial stage than out-dated methods or introspection. In 2016, Niramai was co-founded by Dr Geetha Manjunath and Nidhi Mathur.

For details:

Niramai Health Analytix Pvt Ltd

1st Floor, 1st Main,Opp Bosch Back Gate,

Someshwara Temple Rd, 7th Block,

Koramangala, Bengaluru-560030.

The post Niramai breast cancer detection technology gets international acclaim appeared first on Health Vision.